Your browser doesn't support javascript.
loading
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial.
Erba, Harry P; Montesinos, Pau; Kim, Hee-Je; Patkowska, Elzbieta; Vrhovac, Radovan; Zák, Pavel; Wang, Po-Nan; Mitov, Tsvetomir; Hanyok, James; Kamel, Yasser Mostafa; Rohrbach, Jaime E Connolly; Liu, Li; Benzohra, Aziz; Lesegretain, Arnaud; Cortes, Jorge; Perl, Alexander E; Sekeres, Mikkael A; Dombret, Hervé; Amadori, Sergio; Wang, Jianxiang; Levis, Mark J; Schlenk, Richard F.
Afiliação
  • Erba HP; Duke Cancer Institute, Durham, NC, USA. Electronic address: harry.erba@duke.edu.
  • Montesinos P; Hematology Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
  • Kim HJ; Department of Hematology, Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Patkowska E; Institute of Hematology and Blood Transfusion, Warsaw, Poland.
  • Vrhovac R; Division of Hematology, University Hospital Centre Zagreb, University of Zagreb School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Zák P; Department of Internal Medicine-Haematology, University Hospital Hradec Kralove, Hradec Kralove, Czechia.
  • Wang PN; Chang Gung Medical Foundation, Linkou, Taiwan.
  • Mitov T; Daiichi Sankyo UK, London, UK.
  • Hanyok J; Daiichi Sankyo, Basking Ridge, NJ, USA.
  • Kamel YM; Daiichi Sankyo, Basking Ridge, NJ, USA.
  • Rohrbach JEC; Daiichi Sankyo, Basking Ridge, NJ, USA.
  • Liu L; Daiichi Sankyo, Basking Ridge, NJ, USA.
  • Benzohra A; Daiichi Sankyo, Basking Ridge, NJ, USA.
  • Lesegretain A; Daiichi Sankyo, Basking Ridge, NJ, USA.
  • Cortes J; Augusta University Medical Center, Augusta University, Augusta, GA, USA.
  • Perl AE; Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA, USA.
  • Sekeres MA; Sylvester Cancer Center, University of Miami Health System, Miami, FL, USA.
  • Dombret H; Saint Louis Hospital, University of Paris, Paris, France.
  • Amadori S; Tor Vergata Polyclinic Hospital Rome, Rome, Italy.
  • Wang J; Institute of Hematology and Blood Diseases Hospital, Tianjin, China.
  • Levis MJ; Division of Hematologic Malignancies, Johns Hopkins University, Baltimore, MD, USA.
  • Schlenk RF; National Center of Tumor Diseases Trial Center, German Cancer Research Center, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
Lancet ; 401(10388): 1571-1583, 2023 05 13.
Article em En | MEDLINE | ID: mdl-37116523
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Leucemia Mieloide Aguda / Benzotiazóis Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Leucemia Mieloide Aguda / Benzotiazóis Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2023 Tipo de documento: Article